Lower Patient Anxiety and Unchanged Levels of Adherence to Hemato-Oncologic Treatment in Response to New Measures to Reduce Hospital Exposure Risk to COVID-19 by Sarid N, Mann S, Herishanu Y, Perry C, Cohen YC, Passage I, Neaman M, Benyamini N, Jean M, Avivi I

Get full text

Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab. by Avivi, I, Chakrabarti, S, Milligan, D, Waldmann, H, Hale, G, Osman, H, Ward, K, Fegan, C, Yong, K, Goldstone, A, Linch, D, Mackinnon, S

Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality. by Chakrabarti, S, Avivi, I, Mackinnon, S, Ward, K, Kottaridis, P, Osman, H, Waldmann, H, Hale, G, Fegan, C, Yong, K, Goldstone, A, Linch, D, Milligan, D

Hematologic malignancies in pregnancy: management guidelines from an international consensus meeting by Lishner, M, Avivi, I, Apperley, J, Dierickx, D, Evens, A, Fumagalli, M, Nulman, I, Oduncu, F, Peccatori, F, Robinson, S, Van Calsteren, K, Vandenbroucke, T, Van den Heuvel, F, Amant, F